Skip to content
PICO Portalanswers from OpenAlex

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

PaperCitations, authors & open-access status

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer have?

PICO Portalcitation count

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer has 639 citations in the OpenAlex counts PICO Portal stores.

When was Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer published?

PICO Portalyear

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer has 1999 year in the PICO Portal index.

What is the open-access status of Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer?

PICO Portaloa status

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer has closed oa status in the PICO Portal index.

What is the DOI of Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer?

PICO Portaldoi

The DOI for Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer is on the source record.

What is the PMID of Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer?

PICO Portalpmid

The PMID for Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer is on the source record.

What is the OpenAlex record for Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer?

PICO Portalopenalex

The OpenAlex for Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial